CAPR vs JAZZ · $1.62B cap vs P/E 1988, rev $2.28B
Capricor Therapeutics Inc (CAPR) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CAPR currently screens at market cap $1.62B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CAPR and JAZZ stock pages for the full models.
Not investment advice.